SCHEMBL8209396

SCHEMBL8209396

COC(=O)[C@H](O)[C@@H](N)CC1CCC1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 17/20 0.49
METAP1 P53582 8/20 0.49
REN P00797 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8202433 1.00 METAP2 (0.49) METAP2METAP1REN
SCHEMBL13347345 1.00 METAP2 (0.49) METAP2METAP1REN
SCHEMBL7328407 0.95 METAP2 (0.55) METAP2METAP1REN
SCHEMBL8175196 0.95 METAP2 (0.55) METAP2METAP1REN
Hydrochloric Acid SCHEMBL9514519 0.93 METAP2 (0.53) METAP2METAP1REN
Hydrochloric Acid SCHEMBL9514516 0.93 METAP2 (0.53) METAP2METAP1REN
SCHEMBL10138824 0.93 METAP2 (0.45) METAP2METAP1REN
SCHEMBL13430909 0.93 METAP2 (0.45) METAP2METAP1REN
Hydrochloric Acid SCHEMBL27076653 0.91 METAP2 (0.44) METAP2METAP1REN
Trifluoroacetic Acid SCHEMBL7327225 0.85 METAP2 (0.50) METAP2METAP1REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100113821-A1 PREPARATION OF 3-AMINO-3-(CYCLOBUTYLMETHYL)-2-(HYDROXY)-PROPIONAMIDE HYDROCHLORIDE SCHERING-PLOUGH CORPORATION (US) 2010-05-06 US disclosed
US-20100113821-A1 PREPARATION OF 3-AMINO-3-(CYCLOBUTYLMETHYL)-2-(HYDROXY)-PROPIONAMIDE HYDROCHLORIDE SCHERING-PLOUGH CORPORATION (US) 2010-05-06 US disclosed
WO-2008082486-A2 PREPARATION OF 3-AMINO-3-(CYCLOBUTYLMETHYL)-2-(HYDROXY)-PROPIONAMIDE HYDROCHLORIDE SCHERING CORPORATION (US) 2008-07-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113821-A1 PREPARATION OF 3-AMINO-3-(CYCLOBUTYLMETHYL)-2-(HYDROXY)-PROPIONAMIDE HYDROCHLORIDE CTRL, DNPEP, DPP3 METAP2 144/4885METAP1 29/4885REN 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.